We created a propensity score to match GLP1-RA users and DDP4i users at a ratio of 1:1 using 120 characteristics selected a priori (listed in Table 1), Variables included: age, gender (self-reported), race and ethnicity (self-reported), demographics, personal history, vital signs, comorbidities, comorbidity and cardiovascular scores, frailty score, healthcare utilization, laboratory values, glucose-lowering medication classes, and other medication classes
Its moisturizing base supports skin comfort after every wash, making it suitable for regular face and body use
While some preclinical studies suggest certain probiotic strains, particularly those from the Lactobacillus and Bifidobacterium genera, might modulate gut hormone secretion, the evidence in humans remains limited and preliminary
The table summarizes their mechanisms of action, reported benefits, and experimental models used to evaluate their efficacy
Semaglutide (Wegovy/Ozempic, Novo Nordisk) and liraglutide (Saxenda, Novo Nordisk) made up 31.4% and 35.3% of all new GLP-1 receptor agonist prescriptions in 2019, respectively
